Richard Buchholz - 19 Aug 2025 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Aug 2025, 16:05:11 UTC
Prior SEC filing
05 Aug 2025
Next SEC filing
02 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz

Key filing fact

Richard Buchholz filed Form 4 for Inspire Medical Systems, Inc. (INSP) on 21 Aug 2025.

Key facts

  • This page summarizes Richard Buchholz's Form 4 filing for Inspire Medical Systems, Inc. (INSP).
  • 7 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 21 Aug 2025, 16:05.

Change

  • Previous filing in this sequence was filed on 05 Aug 2025.
  • Current net transaction value: +$1,083,602.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001737133 Primary reporting owner

Buchholz Richard

Relationship
Chief Financial Officer
Address
C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz
Signature date
21 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSP transaction

Common Stock

Options Exercise

Transaction value
$1,267,279
Shares
+17,849
Change %
+49%
Price
$71.00
Shares after
54,088
Date
19 Aug 2025
Ownership
Direct
Footnotes
F1
INSP transaction

Common Stock

Options Exercise

Transaction value
$301,752
Shares
+7,159
Change %
+13%
Price
$42.15
Shares after
61,247
Date
19 Aug 2025
Ownership
Direct
INSP transaction

Common Stock

Tax liability

Transaction value
$239,046
Shares
-2,649
Change %
-4.3%
Price
$90.24
Shares after
58,598
Date
19 Aug 2025
Ownership
Direct
Footnotes
F2
INSP transaction

Common Stock

Tax liability

Transaction value
$221,466
Shares
-2,455
Change %
-4.2%
Price
$90.21
Shares after
56,143
Date
19 Aug 2025
Ownership
Direct
Footnotes
F2
INSP transaction

Common Stock

Tax liability

Transaction value
$24,917
Shares
-276
Change %
-0.49%
Price
$90.28
Shares after
55,867
Date
19 Aug 2025
Ownership
Direct
Footnotes
F2
INSP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,475
Date
19 Aug 2025
Ownership
By Daughter
INSP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,475
Date
19 Aug 2025
Ownership
By Son
INSP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,475
Date
19 Aug 2025
Ownership
By Son
INSP holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,475
Date
19 Aug 2025
Ownership
By Son

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INSP transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-17,849
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,849
Exercise price
$71.00
Footnotes
F3
INSP transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-7,159
Change %
-100%
Price
$0.000000
Shares after
0
Date
19 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,159
Exercise price
$42.15
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes 113 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on June 30, 2025.

Footnote F2

Represents the number of shares of common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the exercise of Stock Options.

Footnote F3

The option is fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .